Found: 9
Select item for more details and to access through your institution.
Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research.
- Published in:
- Nature Reviews Cancer, 2013, v. 13, n. 4, p. 273, doi. 10.1038/nrc3432
- By:
- Publication type:
- Article
Rethinking ovarian cancer: recommendations for improving outcomes.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Beyond chemotherapy: targeted therapies in ovarian cancer.
- Published in:
- 2009
- By:
- Publication type:
- journal article
A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignancies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
PARP inhibitors: the race is on.
- Published in:
- 2016
- By:
- Publication type:
- commentary
Phase III Randomized Trial of Docetaxel—Carboplatin Versus Paclitaxel—Carboplatin as First-line Chemotherapy for Ovarian Carcinoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2004, v. 96, n. 22, p. 1682
- By:
- Publication type:
- Article
Ovarian cancer: strategies for overcoming resistance to chemotherapy.
- Published in:
- Nature Reviews Cancer, 2003, v. 3, n. 7, p. 502, doi. 10.1038/nrc1123
- By:
- Publication type:
- Article
Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0047020
- By:
- Publication type:
- Article
A HIF-Regulated VHL-PTP1B-Src Signaling Axis Identifies a Therapeutic Target in Renal Cell Carcinoma.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 85, p. 1, doi. 10.1126/scitranslmed.3002004
- By:
- Publication type:
- Article